Clinical Trials on Skin Metabolism in United Kingdom
Total 41031 results
-
Gilead SciencesCompletedLipodystrophyUnited Kingdom
-
Cambridge University Hospitals NHS Foundation TrustRecruitingDiabetes | Diet Modification | LipodystrophyUnited Kingdom
-
University of ExeterWithdrawnHealthy | Lipodystrophy, Familial PartialUnited Kingdom
-
Manchester University NHS Foundation TrustOrchard TherapeuticsRecruitingMucopolysaccharidosesUnited Kingdom
-
Alnylam PharmaceuticalsTerminated
-
University of NottinghamArthritis Research UKCompleted
-
Manchester Royal Eye HospitalBioMarin PharmaceuticalUnknownMucopolysaccharidosesUnited Kingdom
-
University of AberdeenCompletedMetabolism Disorder, GlucoseUnited Kingdom
-
Sheffield Hallam UniversityCherry Research CommitteeUnknown
-
University College, LondonCompletedDiabetes Mellitus Foot UlcerUnited Kingdom
-
University of LeedsUniversity of Oslo; The Leeds Teaching Hospitals NHS TrustRecruitingObesity | Breast Cancer | HypercholesterolemiaUnited Kingdom
-
University of EdinburghUnknown
-
University of BathCompletedGlucose Metabolism DisordersUnited Kingdom
-
Ultragenyx Pharmaceutical IncCompleted
-
Nottingham University Hospitals NHS TrustDiabetes UKCompletedFoot Ulceration in DiabetesUnited Kingdom
-
King's College LondonCompletedGlucose Metabolism Disorders | Appetitive BehaviorUnited Kingdom
-
Keele UniversityCompleted
-
University of ManchesterUniversity College, London; Manchester University NHS Foundation Trust; Orchard... and other collaboratorsActive, not recruitingMucopolysaccharidosis Type IIIAUnited Kingdom
-
King's College LondonUnknownGlucose Metabolism Disorders | Appetitive BehaviorUnited Kingdom
-
GlaxoSmithKlineCompletedAtherosclerosisUnited Kingdom
-
Royal Devon and Exeter NHS Foundation TrustUniversity of ExeterCompleted
-
University of AberdeenActive, not recruitingGlucose Metabolism Disorders | Glucose IntoleranceUnited Kingdom
-
Alexion PharmaceuticalsTerminatedMucopolysaccharidosis III, Type B (MPS IIIB) | Sanfilippo BUnited Kingdom
-
Alexion PharmaceuticalsCompletedMPS IIIB (Sanfilippo B Syndrome)United Kingdom
-
OrphalanCompletedWilson's DiseaseUnited Kingdom
-
Alexion Pharmaceuticals, Inc.CompletedWilson DiseaseUnited Kingdom
-
BioMarin PharmaceuticalCompleted
-
Hospira, now a wholly owned subsidiary of PfizerCompleted
-
University of ChichesterCompletedDiabetic Foot | Foot Diseases | Health BehaviorUnited Kingdom
-
Loughborough UniversityActive, not recruitingLipid Metabolism Disorders | Appetitive Behavior | Glucose Metabolism Disorders (Including Diabetes Mellitus)United Kingdom
-
ShireCompletedMucopolysaccharidosis (MPS)United Kingdom, Netherlands
-
Dr. Schär AG / SPACompletedPhenylketonurias | Inborn Errors of Metabolism | Metabolic Disease | PKUUnited Kingdom
-
NorthSea Therapeutics B.V.CompletedDyslipidemiasUnited Kingdom
-
Kathryn BeardsallCompleted
-
Mitsubishi Tanabe Pharma CorporationCompleted
-
Staffordshire UniversitySuspendedDiabetes | Diabetic Foot | Diabetes Complications | Diabetes; Neuropathic (Manifestation)United Kingdom
-
University Hospitals of Derby and Burton NHS Foundation...Wellcome Trust; Nottingham University Hospitals NHS Trust; BioPhage Theraputics...WithdrawnDiabetes | Diabetic Foot | Diabetic Foot InfectionUnited Kingdom
-
University of LeedsCompletedHyperglycaemiaUnited Kingdom
-
Birmingham Women's and Children's NHS Foundation...BioMarin PharmaceuticalWithdrawnMucopolysaccharidosis IV | Morquio A DiseaseUnited Kingdom
-
Vital Signs Solutions LtdRecruiting
-
Loughborough UniversityUniversity of BedfordshireCompletedPostprandial HyperglycemiaUnited Kingdom
-
Manchester University NHS Foundation TrustCompletedHypercholesterolemiaUnited Kingdom
-
The Leeds Teaching Hospitals NHS TrustUnknown
-
Regeneron PharmaceuticalsCompletedFamilial Partial Lipodystrophy | Metabolic AbnormalitiesUnited States, France, Spain, Turkey, United Kingdom
-
Quadram Institute BioscienceCompleted
-
Esperion Therapeutics, Inc.CompletedHyperlipidemiaUnited Kingdom
-
University of NottinghamUnknownInsulin ResistanceUnited Kingdom
-
Xention LtdCompleted
-
Keele UniversityBaxter Healthcare Corporation; National Institute for Health Research, United... and other collaboratorsCompletedGlucose Metabolism DisordersUnited Kingdom